Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Botulinum toxin type A as dermatology remedy

June 14, 1996

Positive phase III results for Phytopharm's Zemaphyte

June 14, 1996

Amgen reveals polypeptide KGF analogues

June 14, 1996

Excellent preclinical results of Repel announced

June 14, 1996

New topical corticosteroids from Hoechst

June 14, 1996

Favorable trial results with interferon gamma-1b for atopic dermatitis and keloids

June 7, 1996

Collagen Corp. acquires distribution rights to Tissue Technologies' ePTFE implant

June 7, 1996

Synthetic retinoid analogue cleared for U.S. market

June 7, 1996

Oclassen obtains rights to 5-MOP

June 7, 1996

Retinoid antagonists revealed by Eisai

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...